Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 12 of 20
Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
NCT03182738
Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal)
NCT02862912
Impact of Sleep Restriction on Performance in Adults
NCT02960776
Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting
NCT03069742
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
NCT02895789
Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas
NCT02978859
Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma
NCT02867618
Influenza Vaccine Randomized Educational Trial: Adult
NCT02907645
Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis
NCT02981706
Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
NCT02984891
Physical Telerehabilitation in Multiple Sclerosis
NCT03230903
Family Nurture Intervention, A Group Model in Connecticut
NCT02970565
Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD)
NCT02904356
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
NCT03038308
Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric
NCT02907580
Health in Individuals With a Spinal Cord Injury: a Prospective Study
NCT03743077
Renal Artery Dopplers in Twin Twin Transfusion Syndrome
NCT03449823
Impact of Sleep Restriction in Women
NCT02835261
Investigating the Effects of Cocoa Flavanol on Cognition Assessed Online
NCT04582617
Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML
NCT02891278
Bone MicroArchitecture in Acromegaly
NCT03225040
Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty
NCT02777749
Contextualizing & Responding to HIV Risk Behaviors
NCT03300908
Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
NCT03626246
Transabdominal and Transvaginal Sonography in Medical Abortion
NCT03047551
Optical Tomography in Prostate Cancer
NCT03215992
Genomic Translation for Amyotrophic Lateral Sclerosis Care
NCT02795897
Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
NCT02716038
The READ-SG Study: Effect of Peer-Facilitated Small Group Discussions
NCT03163251
VircapSeq Virus Detection in Sézary Syndrome
NCT02836886
Music in the Emergency Department (ED)
NCT03047915
Genetic Predictors of Benefit to Pembrolizumab
NCT02710396
Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores
NCT02779426
AirSeal®Insufflation Trocar/CO2 Absorption Study
NCT02654808
Value of 3D Modeling in Spine Surgery
NCT02771899
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
NCT02676843
A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results
NCT02355080
Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study
NCT02954900
ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer
NCT02632071
Blue Blockers at Night and Insomnia Symptoms
NCT02698800
Diet and Physical Activity Changes Among Latina Breast Cancer Survivors
NCT02780271
The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery
NCT02767427
Effects of Sleep Restriction on BAT Activation in Humans
NCT02770118
Hip Hop Stroke: Statewide Dissemination of a School-based Public Stroke Education Intervention
NCT03848364
Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
NCT02702102
PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evaluation of FFR Measurements
NCT02648230
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
NCT02641158
Multimedia WORTH With Black Drug-Involved Women on Probation
NCT02391233
Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance
NCT02585843
Risk of Wrong-Patient Errors With Multiple Records Open
NCT02876588
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.